Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.
作者信息
Di Minno Giovanni, Tremoli Elena
机构信息
Clinica Medica, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli "Federico II", Naples, Italy
Centro Cardiologico Monzino, IRCCS, Milano, Italy.
出版信息
Haematologica. 2017 Mar;102(3):411-418. doi: 10.3324/haematol.2016.156000. Epub 2017 Feb 28.
Abstract
摘要
相似文献
1
Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine.
Haematologica. 2017 Mar;102(3):411-418. doi: 10.3324/haematol.2016.156000. Epub 2017 Feb 28.
2
Current use of biologicals in thrombosis and haemostasis.
Thromb Haemost. 2008 May;99(5):805-6. doi: 10.1160/TH08-04-0201.
3
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
Thromb Res. 2016 Aug;144:133-5. doi: 10.1016/j.thromres.2016.05.024. Epub 2016 May 25.
4
Personalized medicine in thrombosis: back to the future.
Blood. 2016 Jun 2;127(22):2665-71. doi: 10.1182/blood-2015-11-634832. Epub 2016 Feb 4.
5
Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.
Lifestyle Genom. 2018;11(1):1-8. doi: 10.1159/000492297. Epub 2018 Jul 26.
6
Fibrinogen and Fibrin in Hemostasis and Thrombosis.
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e13-e21. doi: 10.1161/ATVBAHA.117.308564.
7
International Society of Thrombosis and Hemostasis--XIXth Congress 12-18 July 2003, Birmingham, UK.
IDrugs. 2003 Sep;6(9):858-61.
8
[Therapeutic concentrates from blood donor components and hemostasis].
Probl Gematol Pereliv Krovi. 1979 Feb;24(2):3-7.
9
A peanut factor for haemostasis in haemophilia.
Nature. 1960 Feb 13;185(4711):469-70. doi: 10.1038/185469a0.
10
Management of coagulation abnormalities in liver disease.
Expert Rev Gastroenterol Hepatol. 2015 Jan;9(1):103-14. doi: 10.1586/17474124.2014.934673. Epub 2014 Jun 26.
引用本文的文献
1
Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapies.
Haematologica. 2024 Dec 1;109(12):3879-3891. doi: 10.3324/haematol.2023.284622.
2
Digital Personal Health Coaching Platform for Promoting Human Papillomavirus Infection Vaccinations and Cancer Prevention: Knowledge Graph-Based Recommendation System.
JMIR Form Res. 2023 Nov 15;7:e50210. doi: 10.2196/50210.
3
Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.
Int J Mol Sci. 2022 May 6;23(9):5213. doi: 10.3390/ijms23095213.
4
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.
J Blood Med. 2021 Oct 21;12:897-911. doi: 10.2147/JBM.S325031. eCollection 2021.
5
Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.
Intern Emerg Med. 2018 Jun;13(4):463-465. doi: 10.1007/s11739-018-1829-7. Epub 2018 Mar 14.
本文引用的文献
1
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.
2
Precision medicine in cardiology.
Nat Rev Cardiol. 2016 Oct;13(10):591-602. doi: 10.1038/nrcardio.2016.101. Epub 2016 Jun 30.
3
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.
Haemophilia. 2016 Sep;22(5):676-83. doi: 10.1111/hae.12970. Epub 2016 Jun 28.
4
Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
Curr Opin Immunol. 2016 Oct;42:31-40. doi: 10.1016/j.coi.2016.05.003. Epub 2016 Jun 2.
5
N-of-1 trials to enhance patient outcomes: identifying effective therapies and reducing harms, one patient at a time.
J Clin Epidemiol. 2016 Aug;76:6-8. doi: 10.1016/j.jclinepi.2016.03.028. Epub 2016 Apr 29.
6
N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis.
J Clin Epidemiol. 2016 Aug;76:65-75. doi: 10.1016/j.jclinepi.2016.03.026. Epub 2016 Apr 20.
7
Opportunities for the Cardiovascular Community in the Precision Medicine Initiative.
Circulation. 2016 Jan 12;133(2):226-31. doi: 10.1161/CIRCULATIONAHA.115.019475.
8
Economic Benefits of Investing in Women's Health: A Systematic Review.
PLoS One. 2016 Mar 30;11(3):e0150120. doi: 10.1371/journal.pone.0150120. eCollection 2016.
9
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
J Thromb Thrombolysis. 2016 Apr;41(3):374-83. doi: 10.1007/s11239-015-1264-9.
10
Public Health in the Precision-Medicine Era.
N Engl J Med. 2015 Aug 6;373(6):499-501. doi: 10.1056/NEJMp1506241.
Zotero 插件